Title of article :
The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer
Author/Authors :
Khatami, Fatemeh Urology Research Center - Tehran University of Medical Sciences - Tehran, Iran , Sadat Aghamir, Zahra Faculty of Dentistry - Tehran University of Medical Sciences - Tehran, Iran , Jahanshahi, Fatemeh Iran University of Medical Sciences - Tehran, Iran , Feiz-Abadi, Ariana Urology Research Center - Tehran University of Medical Sciences - Tehran, Iran , Birang, Fatemeh Department of Medical Laboratory Sciences - Allied Medical Faculty - Tehran University of Medical Sciences - Tehran, Iran , Khoshchehreh, Mahdi Department of Pathology - University of California - Los Angeles, USA , Namazi Shabestari, Alireza Department of Geriatric Medicine - School of Medicine - Tehran University of Medical Sciences - Tehran, Iran , Aghamir, Mohammad Kazem Urology Research Center - Tehran University of Medical Sciences - Tehran, Iran
Pages :
14
From page :
1
To page :
14
Abstract :
Context: The immune system is directly linked to the tumors, from tumor formation to the tumor’s development and metastasis. So, the interest of scientists over the protective immunological mechanisms has increased and shown gifted strategy in cancer treatment. Evidence acquisition: Genetic engineering and cellular immunotherapy are two different advanced molecular mechanisms to modify the immune responses and genome. Gene manipulation is the bioengineering technology that allows vectors to transfer new genetic information into the target cells. Cellular immunotherapy is an excellent strategy that connects the body’s immune system to fight cancer. Results & Conclusions: This review described that combination of genetic engineering and cellular immunotherapy has brought the novel antitumor repressive molecules stopping the tumor tissue immune tolerance and significantly expanding cancer therapy’s effectiveness. Usually, cell immunotherapy and genetic engineering are considered two independent processes, and, in this review, we believe them in combinations. Here, we review these two novel approaches, and they are both combinations in terms of technological advances and clinical experience.
Keywords :
Chimeric Antigen Receptor T cell , Engineered T cell receptor , Natural Killer cell , Tumor-Infiltrating Lymphocyte
Journal title :
Iranian Journal of Biotechnology (IJB)
Serial Year :
2022
Record number :
2731555
Link To Document :
بازگشت